Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease
Journal of Alzheimer’s Disease · 2023
DOI: 10.3233/jad-220460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von C Kathleen Dorey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, White Matter. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Oxidative stress contributes to pathogenesis and progression of Alzheimer’s disease (AD). Higher levels of the dietary antioxidants— carotenoids and tocopherols— are associated with better cognitive functions and lower risk for AD, and lower levels of multiple carotenoids are found in serum and plasma of patients with AD. Although brains donated by individuals with mild cognitive impairment had significantly lower levels of lutein and beta-carotene, previous investigators found no significant difference in carotenoid levels of brains with AD and cognitively normal brains.
Objective
This study tested the hypothesis that micronutrients are significantly lower in donor brains with AD than in healthy elderly brains.
Methods
Samples of donor brains with confirmed AD or verified health were dissected into grey and white matter, extracted with organic solvents and analyzed by HPLC.
Results
AD brains had significantly lower levels of lutein, zeaxanthin, anhydrolutein, retinol, lycopene, and alpha-tocopherol, and significantly increased levels of XMiAD, an unidentified xanthophyll metabolite. No meso-zeaxanthin was detected. The overlapping protective roles of xanthophylls, carotenes, α- and γ-tocopherol are discussed.
Conclusion
Brains with AD had substantially lower concentrations of some, but not all, xanthophylls, carotenes, and tocopherols, and several-fold higher concentrations of an unidentified xanthophyll metabolite increased in AD (XMiAD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
- ZeaVision, Chesterfield, MO, USA.
- Alzheimer's Disease Research Center, Massachusetts General Hospital Boston, MA, USA.
- Center for Biostatistics and Health Data Science, Virginia Tech, Roanoke, VA, USA.
- Craft Technologies, Inc., Wilson, NC, USA.
Zitieren
APA
Dorey, C. K., Gierhart, D., Fitch, K. A., Crandell, I., & Craft, N. E. (2023). Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-220460
Vancouver
Dorey CK, Gierhart D, Fitch KA, Crandell I, Craft NE. Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-220460
BibTeX
@article{Dorey2023,
author = {Dorey, C Kathleen and Gierhart, Dennis and Fitch, Karlotta A and Crandell, Ian and Craft, Neal E},
title = {Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with Alzheimer’s Disease},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
doi = {10.3233/jad-220460}
}
EUVIMED